Novavax
NVAX
#5514
Rank
โ‚น137.82 B
Marketcap
โ‚น838.14
Share price
3.74%
Change (1 day)
55.68%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): โ‚น39.18 Billion

According to Novavax's latest financial reports the company's current earnings are โ‚น1.08 Billion. , an increase over its 2024 earnings that were of -โ‚น14.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น43.86 B-396.87%
2024 -โ‚น14.78 Billion-70.39%
2023 -โ‚น49.9 Billion-16.59%
2022 -โ‚น59.82 Billion-62.58%
2021 -โ‚น159.87 Billion320.54%
2020 -โ‚น38.02 Billion234.22%
2019 -โ‚น11.38 Billion-30.17%
2018 -โ‚น16.29 Billion1.69%
2017 -โ‚น16.02 Billion-36.44%
2016 -โ‚น25.21 Billion70.4%
2015 -โ‚น14.79 Billion89.27%
2014 -โ‚น7.82 Billion59.83%
2013 -โ‚น4.89 Billion81.9%
2012 -โ‚น2.69 Billion50.33%
2011 -โ‚น1.79 Billion
2009 -โ‚น3.53 Billion8.8%
2008 -โ‚น3.25 Billion18.01%
2007 -โ‚น2.75 Billion18.33%
2006 -โ‚น2.33 Billion168.31%
2005 -โ‚น0.87 Billion-62.51%
2004 -โ‚น2.31 Billion52.4%
2003 -โ‚น1.52 Billion-28.21%
2002 -โ‚น2.12 Billion
2000 -โ‚น1.21 Billion177%
1999 -โ‚น0.44 Billion-11.54%
1998 -โ‚น0.5 Billion10.64%
1997 -โ‚น0.45 Billion-9.62%
1996 -โ‚น0.5 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.489 T 3,296.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น999.63 B 2,179.04%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.384 T 3,055.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น944.92 B 2,054.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚น66.28 Billion-251.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น27.13 Billion-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น1.95 B-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚น0.77 Billion-101.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น25.23 B-42.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น15.60 B-64.43%๐Ÿ‡บ๐Ÿ‡ธ USA